TP53 and small cell lung carcinoma: Two SCLC cell lines, NCI‐H792 (p53 mut, Rb wild‐type) and GLC4 (p53 mut, Rb mut), were exposed to increasing concentrations of prexasertib (from 100 nm to 1 μm) for over a period of at least 3 months.